Reactive Airway Disease ICD-10-CM Codes | 2023
Discover the comprehensive ICD-10-CM codes for Reactive Airway Disease, assisting in accurate diagnosis and treatment. Enhance patient care today!
.jpg)
Fact Checked by Nate Lacson.
What ICD-10 Codes are Used for Reactive Airway Disease?
Reactive Airway Disease (RAD) refers to a condition characterized by reversible airway constriction and inflammation in response to various stimuli. It is commonly associated with asthma and shares similar symptoms. Accurate coding of RAD is crucial for proper diagnosis and effective management. Here are some commonly used ICD-10-CM codes for Reactive Airway Disease:
J45.20 - Mild intermittent asthma
This code is used when a patient exhibits occasional asthma symptoms with minimal impairment of daily activities. It signifies a milder form of RAD.
J45.21 - Mild persistent asthma
This code is assigned when a patient experiences asthma symptoms more frequently, impacting their daily activities more than intermittent asthma.
J45.30 - Moderate intermittent asthma
This code indicates that the patient has occasional moderate asthma symptoms, leading to more significant limitations in their daily activities.
J45.31 - Moderate persistent asthma
Patients with this code experience asthma symptoms more regularly and with greater severity than those with intermittent asthma. Their daily activities are moderately affected.
J45.40 - Severe intermittent asthma
This code represents infrequent but severe asthma symptoms significantly impair the patient's daily activities.
J45.41 - Severe persistent asthma
Patients assigned this code experience frequent and severe asthma symptoms, which persist over time and severely limit their daily activities.
J45.50 - Corticosteroid-dependent asthma
This code is used when a patient's asthma requires long-term treatment with corticosteroids to maintain control and prevent exacerbations.
J45.901 - Exercise-induced bronchospasm
This code signifies the occurrence of bronchospasm specifically triggered by physical exertion or exercise.
J45.909 - Unspecified asthma
This code is assigned when insufficient information is available to specify the type or severity of asthma, but the diagnosis of RAD is still appropriate.
J98.01 - Acute bronchospasm
While not specific to RAD, this code may be used when a patient experiences sudden and severe bronchospasm, a hallmark of reactive airway disease.
Which Reactive Airway Disease ICD codes are Billable:
Here is a breakdown of whether commonly used Reactive Airway Disease (RAD) ICD-10-CM codes are billable or not:
J45.20 - Mild intermittent asthma
Yes, this code is billable as it represents a specific and billable diagnosis for RAD with mild, intermittent symptoms.
J45.21 - Mild persistent asthma
Yes, this code is billable as it signifies a distinct and billable diagnosis for RAD with mild but persistent symptoms.
J45.30 - Moderate intermittent asthma
Yes, this code is billable as it represents a specific and billable diagnosis for RAD with moderate, intermittent symptoms.
J45.31 - Moderate persistent asthma
Yes, this code is billable as it signifies a distinct and billable diagnosis for RAD with moderate and persistent symptoms.
J45.40 - Severe intermittent asthma
Yes, this code is billable as it represents a specific and billable diagnosis for RAD with severe, intermittent symptoms.
J45.41 - Severe persistent asthma
Yes, this code is billable as it signifies a distinct and billable diagnosis for RAD with severe and persistent symptoms.
J45.50 - Corticosteroid-dependent asthma
Yes, this code is billable as it represents a specific and billable diagnosis for RAD requiring long-term corticosteroid treatment.
J45.901 - Exercise-induced bronchospasm
Yes, this code is billable as it represents a specific and billable diagnosis for RAD triggered by exercise.
J45.909 - Unspecified asthma
Yes, this code is billable as it represents a distinct and billable diagnosis for RAD when there is insufficient information to specify the type or severity.
J98.01 - Acute bronchospasm
No, this code is not specific to RAD and represents a symptom rather than a specific RAD diagnosis. It may only be directly billable for RAD if documented as a disease manifestation.
Clinical Information
- Reactive Airway Disease (RAD) is a condition characterized by reversible airway constriction and inflammation.
- RAD is often associated with asthma and shares similar symptoms.
- The airway constriction and inflammation in RAD are triggered by various stimuli, such as allergens, respiratory infections, exercise, or irritant exposure.
- Common symptoms of RAD include coughing, wheezing, shortness of breath, chest tightness, and difficulty breathing.
- RAD is diagnosed based on the patient's medical history, physical examination, and pulmonary function tests.
- Treatment for RAD aims to control symptoms, reduce airway inflammation, and prevent exacerbations.
- Medications commonly used for RAD include bronchodilators (e.g., short-acting beta-agonists), inhaled corticosteroids, and leukotriene modifiers.
- Environmental modifications, such as avoiding triggers and improving indoor air quality, can also help manage RAD.
- Patient education on recognizing triggers, proper inhaler technique, and self-management strategies are essential for effective RAD management.
- Regular follow-up visits and monitoring of lung function are necessary to assess treatment effectiveness and adjust the management plan accordingly.
Synonyms Include:
- Bronchial Hyperreactivity
- Bronchial Hyperresponsiveness
- Non-specific Airway Hyperreactivity
- Exercise-Induced Asthma (EIA)
- Irritant-Induced Asthma
- Reactive Bronchospasm
- Hyperactive Airway Disease
- Constrictive Airway Disease
Commonly asked questions
The diagnosis of RAD is typically made based on the patient's medical history, symptoms, physical examination, and pulmonary function tests. Diagnostic tests, such as bronchoprovocation or allergy testing, may be conducted to assess airway reactivity or identify triggers.
Common symptoms of RAD include coughing, wheezing, shortness of breath, chest tightness, and difficulty breathing. These symptoms may be triggered by exposure to allergens, irritants, exercise, or respiratory infections.
The treatment of RAD aims to control symptoms, reduce airway inflammation, and prevent exacerbations. It often includes bronchodilators (such as short-acting beta-agonists), inhaled corticosteroids, leukotriene modifiers, and environmental modifications (e.g., avoiding triggers, improving indoor air quality).
RAD is a chronic condition, and while it can be effectively managed and controlled, there is currently no known cure. Individuals with RAD can lead normal and active lives with proper treatment and self-management strategies.
